Trials / Completed
CompletedNCT01898624
Specified Drug Use-results Survey of Betanis Tablets
Specified Drug Use-results Survey of Betanis Tablets in OAB Patients With Coexisting Glaucoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
To investigate the effects of mirabegron on the symptoms of glaucoma in overactive bladder (OAB) patients with coexisting glaucoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mirabegron | oral |
Timeline
- Start date
- 2012-12-04
- Primary completion
- 2018-01-10
- Completion
- 2018-01-10
- First posted
- 2013-07-12
- Last updated
- 2018-02-05
Locations
7 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01898624. Inclusion in this directory is not an endorsement.